Latest News and Press Releases

- Michelle Lock Joins Covis Pharma as Chief Operating Officer.- Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business. ZUG, Switzerland,...

ZUG, Switzerland, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening...

GUELPH, Ontario, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Canada Ltd. is pleased to announce that it has entered into an Exclusive Promotion and Distribution Agreement with Novartis...

ZUG, Schweiz, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Die Covis Pharma Group („Covis“), ein globales spezialisiertes Pharmaunternehmen, das therapeutische Lösungen für Patienten mit lebensbedrohlichen und...

ZOUG, Suisse, 05 janv. 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (« Covis »), une société pharmaceutique spécialisée d'envergure internationale qui commercialise des solutions thérapeutiques pour...

- Ernennung von Raghav Chari zum Chief Innovation Officer, der das Produktportfolio-Lebenszyklusmanagement leiten soll.- Ernennung von Nicolas Verbeke zum Senior Vice President, Europe &...

-Nomination de Raghav Chari au poste de directeur de l'innovation pour diriger la gestion du cycle de vie du portefeuille de produits.-Nomination de Nicolas Verbeke au poste de vice-président...

-Appointment of Raghav Chari as Chief Innovation Officer to lead product portfolio lifecycle management.-Appointment of Nicolas Verbeke as Senior Vice President, Europe & International, to lead...

ZUG, Switzerland, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (“Covis”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening...

ZUG, Switzerland, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Covis Pharma GmbH (“Covis”) and Norgine B.V. (“Norgine”) today announced data demonstrating the investigational anticoagulant reversal agent,...